110 related articles for article (PubMed ID: 27768165)
1. Better Outcomes for Lower Costs in Breast Cancer Care: Finding a Way.
Newcomer LN
JAMA Oncol; 2017 Mar; 3(3):309-310. PubMed ID: 27768165
[No Abstract] [Full Text] [Related]
2. Medical costs associated with metastatic breast cancer in younger, midlife, and older women.
Trogdon JG; Baggett CD; Gogate A; Reeder-Hayes KE; Rotter J; Zhou X; Ekwueme DU; Fairley TL; Wheeler SB
Breast Cancer Res Treat; 2020 Jun; 181(3):653-665. PubMed ID: 32346820
[TBL] [Abstract][Full Text] [Related]
3. Medical Care Costs of Breast Cancer in Privately Insured Women Aged 18-44 Years.
Allaire BT; Ekwueme DU; Guy GP; Li C; Tangka FK; Trivers KF; Sabatino SA; Rodriguez JL; Trogdon JG
Am J Prev Med; 2016 Feb; 50(2):270-7. PubMed ID: 26775906
[TBL] [Abstract][Full Text] [Related]
4. Cost analysis of leuprorelin acetate in Japanese pre-menopausal breast-cancer patients: comparison between 6-month and 3-month depot formulations.
Goto R; Uda A; Hiroi S; Iwasaki K; Takashima K; Kurebayashi J
J Med Econ; 2017 Nov; 20(11):1163-1169. PubMed ID: 28782387
[TBL] [Abstract][Full Text] [Related]
5. Treatment Costs of Breast Cancer Among Younger Women Aged 19-44 Years Enrolled in Medicaid.
Ekwueme DU; Allaire BT; Guy GP; Arnold S; Trogdon JG
Am J Prev Med; 2016 Feb; 50(2):278-85. PubMed ID: 26775907
[TBL] [Abstract][Full Text] [Related]
6. Total and out-of-pocket expenditures among women with metastatic breast cancer in low-deductible versus high-deductible health plans.
Leopold C; Wagner AK; Zhang F; Lu CY; Earle CC; Nekhlyudov L; Ross-Degnan D; Wharam JF
Breast Cancer Res Treat; 2018 Sep; 171(2):449-459. PubMed ID: 29855813
[TBL] [Abstract][Full Text] [Related]
7. Association between medical home enrollment and health care utilization and costs among breast cancer patients in a state Medicaid program.
Kohler RE; Goyal RK; Lich KH; Domino ME; Wheeler SB
Cancer; 2015 Nov; 121(22):3975-81. PubMed ID: 26287506
[TBL] [Abstract][Full Text] [Related]
8. Cost drivers for breast, lung, and colorectal cancer care in a commercially insured population over a 6-month episode: an economic analysis from a health plan perspective.
Sagar B; Lin YS; Castel LD
J Med Econ; 2017 Oct; 20(10):1018-1023. PubMed ID: 28581874
[TBL] [Abstract][Full Text] [Related]
9. Estimating the costs of caring for the older breast cancer patient.
Hayman JA; Langa KM
Crit Rev Oncol Hematol; 2003 Jun; 46(3):255-60. PubMed ID: 12791425
[TBL] [Abstract][Full Text] [Related]
10. Household costs of breast cancer morbidity: An empirical assessment from Pakistan.
Zahid Mahmood H; Khaliq IH; Bhatti ZI; Wilson KJ; Gondal KM; Malik S; Zaman S
J BUON; 2018 Dec; 23(7):28-33. PubMed ID: 30722109
[TBL] [Abstract][Full Text] [Related]
11. Consumer response to incentives under alternative health insurance programs.
Friedman B
Inquiry; 1973 Sep; 10(3):31-5. PubMed ID: 4269727
[No Abstract] [Full Text] [Related]
12. [Economic evaluation of the new national breast cancer screening programme in France: application to the Bouche-du-Rhone district].
Giorgi R; Reynaud J; Wait S; Seradour B
Bull Cancer; 2005 Nov; 92(11):995-1001. PubMed ID: 16316834
[TBL] [Abstract][Full Text] [Related]
13. Economic burden of malignant blood disorders across Europe: a population-based cost analysis.
Burns R; Leal J; Sullivan R; Luengo-Fernandez R
Lancet Haematol; 2016 Aug; 3(8):e362-70. PubMed ID: 27476787
[TBL] [Abstract][Full Text] [Related]
14. Treatment patterns, clinical outcomes, health resource utilization, and cost in patients with BRCA-mutated metastatic breast cancer treated in community oncology settings.
Houts AC; Olufade T; Shenolikar R; Walker MS; Schwartzberg LS
Cancer Treat Res Commun; 2019; 19():100121. PubMed ID: 30785027
[TBL] [Abstract][Full Text] [Related]
15. Drivers of cost differences between US breast cancer survivors with or without lymphedema.
Dean LT; Ransome Y; Frasso-Jaramillo L; Moss SL; Zhang Y; Ashing K; Denis GV; Frick KD; Visvanathan K; Schmitz KH
J Cancer Surviv; 2019 Oct; 13(5):804-814. PubMed ID: 31446591
[TBL] [Abstract][Full Text] [Related]
16. Cost-Efficiency of Breast Cancer Care in the US Military Health System: An Economic Evaluation in Direct and Purchased Care.
Eaglehouse YL; Georg MW; Richard P; Shriver CD; Zhu K
Mil Med; 2019 Oct; 184(9-10):e494-e501. PubMed ID: 30839064
[TBL] [Abstract][Full Text] [Related]
17. Self-Reported Risk Factors for Financial Distress and Attitudes Regarding Cost Discussions in Cancer Care: A Single-Institution Cross-Sectional Pilot Study of Breast Reconstruction Recipients.
Asaad M; Bailey C; Boukovalas S; Liu J; Clemens MW; Selber J; Butler CE; Offodile AC
Plast Reconstr Surg; 2021 Apr; 147(4):587e-595e. PubMed ID: 33776027
[TBL] [Abstract][Full Text] [Related]
18. An evaluation of the healthcare costs associated with adverse events in patients with breast cancer.
Wang LC; Chen HM; Chen JH; Lin YC; Ko Y
Int J Health Plann Manage; 2021 Sep; 36(5):1465-1475. PubMed ID: 33914358
[TBL] [Abstract][Full Text] [Related]
19. Rural-Urban Differences in Costs of End-of-Life Care for the Last 6 Months of Life Among Patients with Breast, Lung, or Colorectal Cancer.
Crouch E; Eberth JM; Probst JC; Bennett K; Adams SA
J Rural Health; 2019 Mar; 35(2):199-207. PubMed ID: 29656565
[TBL] [Abstract][Full Text] [Related]
20. The impact of outpatient systemic anti-cancer treatment on patient costs and work practices.
Collins DC; Coghlan M; Hennessy BT; Grogan L; Morris PG; Breathnach OS
Ir J Med Sci; 2017 Feb; 186(1):81-87. PubMed ID: 27498210
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
